Upstate Active Clinical Trials

Category	Principal Investigator	Keyword OR ClinicalTrials.Gov ID
Please selectAddictive Behaviors Aging Amyotrophic Lateral Sclerosis (ALS) Arthritis Blood Disorders Bone/Muscle/Joint Disorders Cancer Cardio/Vascular Cystic Fibrosis Diabetes/Endocrinology Epilepsy Healthy Volunteers Immunology Infectious/Immune Disorders Kidney Diseases Lung Disease Men's Health Mental Health Movement Disorders Multiple Sclerosis (MS) Neurological/Nerve Disorders Other Pain Management Parkinson's Disease Pediatrics (Non-Cancer) Rheumatology Stomach/GI Disorders Stroke Surgical Urology Vaccine/Immunization Vision Women's Health	-Any-Kwame S Amankwah Alexander Banashkevich, MD Alina Basnet Robert L Beach Helene Bernstein Timothy M Beutler Jeffrey A Bogart, MD Deborah Y Bradshaw Sharon A Brangman Gennady Bratslavsky, MD Blair Calancie, PhD Melanie A Comito Michael J Costanza Mary J Cunningham, MD Timothy A Damron Joseph B Domachowske Nienke P Dosa Andrea M Dvorak Ahmed Eldokla Timothy P Endy Margaret K Formica Christopher N Fortner, MD Teresa C Gentile, MD, PhD Krishna B Ghimire, MD Stephen L Graziano, MD Seung Shin Hahn, MD David Hansen, MD Joseph M Jacob, MD Brian Johnson William G Kerr Hani Kozman Andrzej Krol Mark Laftavi Julius Gene S Latorre William F Lavelle, MD David F Lehmann Kan Liu Juntao Luo Corey A McGraw Jenny A Meyer Dragos L Mihaila Michael D Mix, MD Philip Monteleone Sriram S Narsipur Christopher G Neville, PT, PhD Kent M Ogden Dorothy C Pan, MD Kristopher M Paolino Andras Perl, MD, PhD Bernard J Poiesz, MD Mark E Polhemus, MD Jeffrey J Pu Elizabeth Asiago Reddy Brian P Rieger Adam P Rufa, DPT, PhD Elena Schmidt Kathryn E Scott Richard J Servatius Rahul Seth, DO Kevin J Setter, MD Anna Shapiro, MD Palma Shaw Brittany A Simone Abirami Sivapiragasam Christine M Stork-Medicis Manika D Suryadevara Amar S Swarnkar Richard A Tallarico Parakulam S Thomas, MD Stephen J Thomas Daniel Y Tso Margaret A Turk, MD Prateek D Wali Claribel D Wee Leonard B Weiner Ruth S Weinstock, MD, PhD Scott V Wiener Eufrosina I Young

You searched for Category (Neurological/Nerve Disorders): 27 trials found.

Click in the column header to sort records.

Study Title	PI
58-Week Open-label Trial of Tavapadon in Parkinson’s Disease (TEMPO-4 Trial) Read more	Dragos L Mihaila
A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson's Disease Read more	Dragos L Mihaila
A First-in-human (FIH) Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) Read more	Robert L Beach
A PHASE 2B/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12 MONTH CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MN-166 (IBUDILAST) FOLLOWED BY AN OPEN-LABEL EXTENSION IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS Read more	Jenny A Meyer
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, FLEXIBLE-DOSE, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TAVAPADON AS ADJUNCTIVE THERAPY FOR PARKINSON'S DISEASE IN LEVODOPA-TREATED ADULTS WITH MOTOR FLUCTUATIONS Read more	Dragos L Mihaila
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, FLEXIBLE-DOSE, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TAVAPADON IN EARLY PARKINSON’S DISEASE Read more	Dragos L Mihaila
A PHASE 3, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF RELDESEMTIV IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) Read more	Deborah Y Bradshaw
A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS) Read more	Eufrosina I Young
A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH OCRELIZUMAB IN ADULT PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS Read more	Corey A McGraw
A pilot study in persons with spinal cord injury: Does Quadro-Pulse transcranial magnetic stimulation (QP-TMS) augment recovery of voluntary movement? Read more	Blair Calancie, PhD
A RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR Read more	Timothy M Beutler
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL GROUP, MULTICENTER TRIAL OF CVL-865 AS ADJUNCTIVE THERAPY IN ADULTS WITH DRUG-RESISTANT FOCAL ONSET SEIZURES Read more	Robert L Beach
A randomized, open label, multi-center, active-comparator study to assess the efficacy, safety and tolerability of ofatumumab 20mg sc monthly versus continued current therapy in relapsing-remitting multiple sclerosis after elevation of serum neurofilament light levels (SOSTOS) Read more	Corey A McGraw
Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recover Read more	Claribel D Wee
ATRI-002: Long-Term Nicotine Treatment of Mild Cognitive Impairment (NIC study) Read more	Sharon A Brangman
DELTA: Does Embolization with Larger coils lead to better Treatment of Aneurysms trial Read more	Amar S Swarnkar
HEALEY ALS Platform Trial Read more	Eufrosina I Young
Home-Based Spirometry through Telemedicine in Amyotrophic Lateral Sclerosis Read more	Eufrosina I Young
Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke Read more	Julius Gene S Latorre
NN6535-4725-A randomized double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer's disease (EVOKE plus) Read more	Sharon A Brangman
PBD 01187: A Phase 2A Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Varoglutamstat (PQ912) in Patients with Early Alzheimer’s Disease with a Stage Gate to Phase 2B (VIVAMIND) Read more	Sharon A Brangman
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction (CHARM) Read more	Julius Gene S Latorre
Sleep-SMART: Sleep for Stroke Management and Recovery Trial Read more	Julius Gene S Latorre
STATINS USE IN INTRACEREBRAL HEMORRHAGE PATIENTS Read more	Elena Schmidt
The association between Autonomic dysfunction in patients with cryptogenic stroke and development of atrial fibrillation. Read more	Ahmed Eldokla
The utility of Stellate Ganglion Blocks in patients with PTSD and Neuropathic pain Read more	Parakulam S Thomas, MD
Transcranial magnetic stimulation for the assessment of upper motor neuron and lower motor neuron contributions to amyotrophic lateral sclerosis (ALS) Read more	Eufrosina I Young

Search Again